Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Isoquercetin and Aspirin on Platelet Function
NCT02866448Withdrawn
- Sponsor
- University of Reading
- Start
- Aug 2016
- Primary completion
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of isoquercetin in cardiovascular disease (CVD), sponsored by University of Reading. Planned start Aug 2016; status: withdrawn.
02
Drugs
isoquercetin
03
Conditions
cardiovascular disease (CVD)
Beyond the preview
Go deeper on NCT02866448.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02866448.